Calcutta Telegraph | Novartis, Biocon lock horns Calcutta Telegraph India is known as the diabetes capital of the world and, therefore, the segment is fiercely competitive with domestic players seeking to make generic versions of popular drugs. This is not the first ... Nexavar is the first-line treatment for liver and ... |
